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MD, PhD, Mathieu Lapeyre, MD, and Hischam Kobeiter, MD, Paris and Creteil, France
Purpose: We assessed the distribution of secondary interventions after aortic stent grafting (EVAR) performed to treat
infrarenal abdominal aortic aneurysm (AAA), and evaluated clinical success and survival in patients who underwent a
secondary procedure (group 2) compared with patients who did not undergo a secondary procedure (group 1).
Methods: Two hundred fifty patients (mean age, 71.3 years) with asymptomatic AAAs (mean aneurysm diameter, 54.5
mm) underwent treatment with commercially available stent grafts. Mean follow-up was 28 months (median, 25
months). Secondary procedures were defined as any additional procedures performed after initial graft placement to treat
endoleak, migration, kinking, stenosis, or occlusion. Overall clinical success was defined according to reporting standards
of the Society for Vascular Surgery/American Association for Vascular Surgery.
Results: Sixty-eight patients (27%) required 112 secondary procedures, with a mean time from initial graft placement of
18.2 months. Patients who received grafts since removed from the market required more secondary procedures (59%,
procedure:patient ratio) compared with patients who received devices still on the market (21%; P  .001). Thirty-six
patients (53%) required a single secondary procedure, 24 patients (35%) required two procedures, 5 patients (10%)
required three procedures, 2 patients (3%) required four procedures, and 1 patient required five secondary procedures.
Ninety-eight procedures (87%) were performed with endovascular methods, including placement of 42 additional
covered stent grafts (36 iliac, 6 aortic), with a success rate of 85%; 35 embolization procedures (21 lumbar, 9 internal iliac
artery, 5 mesenteric), with only 23 (65%) successful; 14 angioplasty procedures, with 85% successful; 4 thrombolysis
procedures, 2 of them successful (50%); and 3 successfully placed new endografts within a previous endovascular graft.
Surgical secondary operations included nine femorofemoral bypass procedures and three femoral thromboendarterecto-
mies, all of which remain patent; one cerclage of an external iliac limb; and one laparoscopic repair of a type II endoleak,
which was successful. Overall clinical success rate for EVAR was 84% (211 of 250) in this series. Clinical success rate in
groups 1 and 2 was 91% (166 of 182) versus 66% (45 of 68; P  .001) if all endoleaks on the most recent computed
tomography scans are taken into account, and 94% (171 of 182) versus 76% (52 of 68; P  .001) if type II endoleak
without aneurysm growth is not considered failure. The survival rate and rupture-free survival in groups 1 and 2 were,
respectively, 97.7%  1.0% and 98.5%  1.4% at 1 month, 95.9%  1.5% and 96.9%  2.1% at 6 months, 94.4%  2.0%
and 93.2%  3.4% at 1 year, and 80.8%  5.2% and 88.5%  5.0% at 3 years (P  .273, log-rank test).
Conclusion: With close follow-up and a significant number of secondary operations, this 8-year experience has not
included any aneurysm ruptures to date. Secondary operations did not lead to increased mortality, but were associated
with more surgical conversions and with a higher clinical failure rate. (J Vasc Surg 2004;39:298-305.)
More than 10 years after the report by Parodi et al1
endovascular treatment of abdominal aortic aneurysm
(AAA) has become popular in the vascular community.
Proved advantages are less blood loss, shorter hospitaliza-
tion time, decreased need for use of the intensive care unit,
less severe postoperative complications, and more rapid
recovery.2,3 On the other hand, extensive follow-up studies
are recommended after endovascular repair, and repeat
interventions are required in 12% to 28% of cases.4-7 Out-
comes of secondary interventions have not been extensively
evaluated and reported.8
The purposes of the current study were to report our
experience with secondary interventions after endovascular
AAA repair in a single academic institution and to assess the
outcomes in terms of survival and efficacy.
METHODS
From January 1, 1995, through December 31, 2002,
evdovascular stent grafts were placed in 268 patients. Data
analysis was limited to 250 patients who received treatment
of nonruptured atherosclerotic abdominal aneurysms.
Eighteen emergent procedures, nonatherosclerotic aneu-
rysms, and aneurysms limited to the iliac arteries were
excluded. All postoperative events which occurred until
April 2003 were taken into account.
Data were prospectively entered into a specifically writ-
ten data base (Logit; Jean Meunier, Fontenay sous Bois,
France). This database was designed with a large emphasis
on patient follow-up. The software was programmed to
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assess, on a monthly basis, overdue examinations and miss-
ing data. The patients were placed in a strict surveillance
protocol. A part-time secretary was hired to telephone
patients to ensure scheduling and compliance. At the ap-
propriate follow-up intervals patients were examined, and
their diagnostic studies were reviewed by senior vascular
surgeons. For patients who died outside of the hospital,
general practitioners were interviewed to assess whether
death was related to aneurysm rupture or to other causes.
Postoperative follow-up included clinical examination,
abdominal plain radiography, duplex scanning, and com-
puted tomography (CT) at 1, 6, 12, and 18 months, and
yearly thereafter.
Secondary procedures were defined as any additional
procedures performed to treat endoleak, graft migration,
kinking, stenosis or occlusion, and landing site enlarge-
ment, while leaving the primary stent graft in place.
Patients were divided into two groups. Group 1 in-
cluded patients in whom secondary procedures were not
necessary or not feasible; group 2 included patients in
whom a secondary procedure was performed. Age, sex,
AAA diameter and extent, preoperative comorbid condi-
tions defined according to Society for Vascular Surgery/
ISCVS risk score, and type of grafts were compared.
We investigated the results of each type of secondary
procedure according to the intended goal, and for groups 1
and 2 compared the role of grafts used, survival rate, and
clinical success as defined by the Committee for Reporting
Standards for Endovascular Repair.9
Indications for secondary intervention
Endoleak. Type I (proximal and distal), type III, and
type IV endoleaks were aggressively treated when techni-
cally accessible. Type II endoleaks were treated if they
persisted on at least two subsequent CT examinations or if
the aneurysm diameter was greater than 5.5 cm or had
enlarged by more than 10%.
Migration. Proximal downstream or distal upstream
graft migration was treated when the covered tips of the
endovascular graft came close (0.5 cm) to the aneurysmal
disease.
Kinking. Severe kinking (90 degrees) of limbs grafts
was treated preemptively.
Stenosis and occlusions. All symptomatic stenotic or
occlusive lesions that developed in either the grafts or the
iliac or common femoral arteries distal to the grafts were
treated aggressively, as were hemodynamically significant
stenoses detected on routine duplex scans. Conversely,
asymptomatic stenoses or occlusions were treated
conservatively.
Landing site enlargement. Common iliac aneurysms
adjacent or distal to the graft landing zone were treated
with additional stents.
Indications for surgical conversion. Patients with
failed endografts who were fit enough to undergo open
surgery were operated on after endovascular attempts
failed, or when endovascular means were not technically
feasible or were hazardous.
Statistical analysis. The 2 test, Mann-Whitney test,
and Student t test were used when appropriate. Survival
data were assessed with life table analysis, and compared
with the log-rank test.
Operative techniques. A variety of techniques were
used, depending on the indication for secondary interven-
tion, nature of the initial grafts, and type of endovascular
tools available at the time of the secondary procedure.
Balloon angioplasty with or without stenting. Ste-
noses that developed in the external iliac artery distal to the
graft were treated with balloon angioplasty through the
ipsilateral groin. Stents were placed only in case of poor
results assessed on intraoperative completion angiograms
and with pressure measurements. In the event of twisting
within a nonsupported graft, long self-expandable stents
were placed to open the stenotic portion and prevent
displacement of the twist proximally or distally along the
graft. Kinking in fully supported grafts was treated either by
placing a new stent within the kinked limb or with femo-
rofemoral grafting when a stent could not be placed. In the
latter case the compromised limb was either ligated or
occluded with an occluder device (Cook, Charenton le
Pont, France). Stenoses that developed at the junction of
the modular components were treated with either balloon-
expandable stents or a new covered stent graft.
Iliac and aortic extensions and cuffs. Iliac extensions
(Boston Scientific, St Quentin en Yvelines, France;
Medtronic, Boulogne Billancourt, France; Cook) were
placed percutaneously or after a short inguinal incision,
with products from the same or another company. When
the extension required placement into the external iliac
artery and crossing of a patent hypogastric artery, the origin
of the hypogastric artery was embolized with coils before-
hand. This was necessary because all of our secondary iliac
extensions required going down to the external iliac level,
because of common iliac enlargement or aneurysm
formation.
Aortic cuffs were introduced from the groin with a
pigtail catheter placed in the aorta from the brachial artery
(left side in most cases). The position of the renal arteries
during deployment was assessed via a wire selectively placed
beforehand (Fig 1, online only). In cases of severe aortic
angulation an extra-large Palmaz stent (Cordis, Issy les
Moulineaux, France) was placed across the renal arteries,
with the distal portion extending down into the graft. The
aortic cuff was then placed inside the Palmaz stent.
Treatment of disconnections. When modular com-
ponents separated, we tried to catheterize both compo-
nents from the groin and to place a new covered stent
within the previous graft (Fig 2, online only).
Endovascular conversion. This strategy involved
placement of a new aortouniiliac graft within the previous
graft. If the first graft was bifurcated, the contralateral limb
was blocked with an occluder. Flow was restored with a
femorofemoral bypass or an iliofemoral bypass graft. Endo-
vascular conversion was particularly useful in cases of failed
attempts to treat severe limb kinking, disconnection with
type III endoleak and type I proximal endoleak, and migra-
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tion. All endovascular conversion procedures were per-
formed with specially customized aortouniiliac grafts (Ze-
nith; Cook).
Embolization. Inferior mesenteric arteries were
blocked at their origins by way of the superior mesenteric
arteries. We used either a femoral or a brachial approach,
depending on the angle between the aorta and the superior
mesenteric artery. The proximal segment of the Drum-
mond arcade was catheterized with a 5F catheter. A 3F
microcatheter was advanced to reach the ostium of the
inferior mesenteric artery. Five to 10 microcoils (Tornado
or spiral coils; Cook), 4 to 5 mm wide and 2 to 3 cm long,
were placed to obtain total occlusion of the proximal trunk
of the inferior mesenteric artery, while the collateral path-
way to the sigmoid arteries was spared. Patent lumbar
arteries were embolized with a similar technique. They
were catheterized from the hypogastric arteries through the
iliolumbar arteries. Whenever necessary, the ostia of the
fourth and fifth lumbar arteries were blocked bilaterally.
Coils and microcoils were used when the microcatheter
could be placed within the sac or at the level of the artery
ostia. Histo-acryl glue (Braun, Boulogne, France) was de-
livered into the trunk of the lumbar artery when the distal
tip of the microcatheter could not reach the ostia itself or
coils were insufficient. The hypogastric arteries were
blocked with coils when a distal extension crossing the
origin of the hypogastric was necessary. We strived to block
the origin of the hypogastric artery and spare the distal
branches. Direct coil embolization of the sac was per-
formed in the operating room, with the technique of Baum
et al.10 The puncture was guided by findings on plain x-ray
films. Combined coil embolization and hysto-acryl injec-
tion was used.
Thrombolysis. After diagnostic angiography, a guide
wire (0.035 inches in diameter, 1.5 m long) and a 5F
multiply perforated polyethylene catheter were placed into
the clot. Urokinase (Actosolv; Hoechts, France) was in-
jected intra-arterially at a dose of 4000 IU/kg/hr for 4
hours; then infusion was slowed to 1000/IU/kg/hr for 24
to 48 hours. When proximal lysis was obtained, the catheter
was advanced farther into the remaining clot. Lytic therapy
was continued for 4 hours if complete lysis was obtained.
Heparin was injected concomitantly through the intro-
ducer at a dose of 20,000 IU/24 hr. Lytic therapy was
stopped if the fibrinogen concentration fell below 1 g/L.
After lysis, severe stenoses or kinking were stented with
either with a Palmaz stent (Cordis) or a Wallstent (Boston
Scientific).
Open adjunct surgery. Subcutaneous femorofemoral
bypass or retropubic iliofemoral bypass was performed to
treat limb graft occlusion that could not be treated with
endovascular means and as an adjunct procedure for endo-
vascular conversion. The repair took into consideration the
status of the hypogastric artery, which was spared when
feasible.
Cerclage. Banding of the iliac artery with a Teflon
sheet was performed through a short retroperitoneal inci-
sion. To determine the tightness of the band and to avoid
creation of a stenosis while treating the leak, we inflated a
balloon within the iliac artery while tying the suture.
Laparoscopic adjuncts. Through a laparoscopic ap-
proach the aneurysm sac was opened, clots were removed,
and backbleeding from the lumbar arteries was stopped
with placement of sutures and clips inside the opened sac.
The aneurysm sac was resected and sutured to reduce the
volume of the aneurysm.
RESULTS
Among the 250 patients included in the current analy-
sis, group 1 included 182 patients in whom no secondary
intervention was performed, and group 2 included 68
patients (27%) who required 112 secondary procedures.
Mean time from initial graft placement to the first second-
ary operation was 18.2 months  8.2 months.
Thirty-six patients (53%) required a single secondary
procedure, 24 patients (35%) required two procedures, 5
patients (10%) required three procedures, 2 (3%) patients
Table I. Demographic data and aneurysm characteristics
in patients without (group 1) vs with (group 2) secondary
procedure after EVAR
Group I
(n  182)
Group II
(n  68) P
Mean age (y) 72  8.7 71  8.5 NS
Male gender (%) 94 93 NS
AAA diameter (mm) 52.2  4.9 55.6  5.1 NS
D/E AAA
classification* (%)
7.2 6.8 NS
Score 3 cardiac
status† (%)
3 4.4 NS
Score 3 pulmonary
status† (%)
6.6 1.5 NS
Score 3 renal status†
(%)
1.6 3 NS
ASA 3/4 (%) 63.2 50 NS
EVAR, Endovascular repair of aneurysm; AAA, abdominal aortic aneurysm;
ASA, American Society of Anesthesiologists.
*EUROSTAR classification. D/E includes aortic aneurysm with iliac exten-
sion close to hypogastric bifurcation; Includes aortic aneurysm with iliac
extension distal to hypogastric bifurcation.
†Society for Vascular Surgery/ISCVS classification.
Table II. Events that led to secondary intervention after
endovascular repair of aortic aneurysm
n %
Type I endoleak, proximal 7 6
Type I endoleak, distal 29 26
Type II endoleak 33 29
Type III endoleak 12 10
Limb occlusion 13 12
Limb stenosis or kinking 8 7
Graft occlusion 2 1.5
Graft migration 4 3
Iliac enlargement 4 3
Total 112 100
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required four procedures, and one patient required five
secondary procedures.
Patient demographic data and aneurysm characteristics
are shown in Table I. There was no statistical difference
between the two groups.
Reasons for secondary intervention are listed in Table
II. Of note, in some patients there was more than one
reason to perform a secondary operation. For example,
migration and kinking or migration and type I endoleak
were frequently associated. In addition, some patients had
multiple and complex combinations of endoleaks.
Distribution of procedures and efficacy of treating the
causes are listed in Table III. Endovascular methods were
used in 98 cases (87%), with generally rewarding results,
except for failure of aortic cuffs in half of the cases, and early
techniques of lumbar embolization. Surgical secondary op-
erations included nine femorofemoral bypass procedures
and three thromboendarterectomies, all of which remain
patent. However, in two patients groin infections devel-
oped that required explantation and new crossover grafts.
The outcomes were favourable, with complete wound heal-
ing and graft patency. One cerclage of an external iliac limb
was initially successful. However, conversion to open sur-
gery was required 8 months later because of a persistent
leak from graft fabric rupture and an enlarging aneurysm.
In another patient with an enlarging aneurysm and type II
endoleak, laparoscopic repair was attempted after failed
lumbar embolization. A control CT scan obtained after 1
month showed exclusion of the aneurysm and reduction of
the sac size. Overall technical success was 79% (89 of 112),
and there were no early deaths after secondary procedures.
We also investigated the role of type of endovascular
grafts used in the requirement for secondary procedures
(Table IV). Twenty-eight of 160 patients (17%) with sup-
ported grafts still commercially available (Cook, Excluder,
AneuRx, Talent), versus 32 of 76 patients (42%) with grafts
removed from the market (Stentor, Vanguard, Stenway) (P
 .06) required one or more secondary procedures. Eight
of 13 patients (61%) who received EVT grafts (Endovascu-
lar Technologies, Menlo Park, Calif) required a secondary
procedure. The ratio of number of procedures/patients
with grafts still commercially available is 59%, versus 21%
for grafts removed from the market (P  .001).
Eleven of 250 patients (4.4%) with stent grafts under-
went explantation of the grafts, three patients in group 1
(1.6%) and eight patients in group 2 (12%) (P .003). The
risk for surgical conversion after endovascular grafting was
15 times greater in patients requiring a secondary operation
than in those who did not need a secondary procedure.
Concerning type of graft, 6 of 76 grafts (7.8%) removed
from the market necessitated conversion, versus 5 of 174
(2.8%) grafts still available (P .158). When comparison is
limited to supported grafts still on the market versus sup-
ported grafts removed from the market, the difference is
statistically significant, respectively, 3 of 160 (1.8%) versus
6 of 76 (7.8%) (P  .05).
Nine patients with fully supported grafts were operated
on through a midline incision and with infrarenal clamping.
Two patients with EVT grafts were treated through a
retroperitoneal approach, with suprarenal clamping. Data
for these patients are shown in Table V. All patients who
underwent conversion to open surgery survived the opera-
tion.
Survival rates for patients with and without the need for
secondary procedures were, respectively, 98.5% 1.4% and
97.7%  1% at 1 month, 96.9%  2.1% and 95.9%  1.5%
at 6 months, 93.2%  3.4% and 94.4%  2% at 1 year, and
88.5% 5% and 80.8% 5.2% at 3 years (P .07, log-rank
test; Fig 3, online only).
Overall clinical success rate of endovascular repair of
AAA was 84% (211 of 250) in this series. For comparison
between groups 1 and 2, the success rate was 91% (166 of
182) versus 66% (45 of 68; P .001) if all endoleaks on the
most recent CT scans are taken into account, and 94% (171
Table III. Distribution of secondary events after EVAR
n
Technical success
n %
Aortic cuff 6 3 50
Limb extension 32 29 90
Limb interposition 4 3 75
Embolization total 35
Internal iliac artery 9 7 77
Lumbar artery 21 12 57
Inferior mesenteric
artery
5 4 80
PTA with or without
stenting
14 12 85
Thrombolysis 4 2 50
Femorofemoral
bypass*
9 9 100*
Iliofemoral repair 3 3 100
Iliac cerclage 1 1 100
Laparoscopic repair 1 1 100
Endovascular
conversion
3 3 100
Total 112 89 79
EVAR, Endovascular repair of aortic aneurysm; PTA, percutaneous trans-
luminal angioplasty.
*Includes two infected grafts that were removed and successfully replaced.
Table IV. Distribution of secondary interventions
according to type of endograft
Endograft
Group I
Patients
Group II
Patients
with
secondary
procedure
(%)Patients Procedures
Stentor 2 6 15 75
Vanguard 40 18 30 31
EVT 5 8 14 61
Talent 5 1 1 16
Stenway 2 8 18 80
Cook 90 21 25 18
AneuRx 17 4 7 19
Excluder 20 2 2 9
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of 182) versus 76% (52 of 68; P .001) if type II endoleaks
without growing aneurysm are not considered failures. Of
interest, no rupture was observed in this series.
DISCUSSION
Our study is in agreement with previous reports that
underlined the frequent need for repeat intervention after
endovascular treatment of AAA. Incidence of repeat inter-
vention was 10% in the Montefiore experience with 239
AAA followed up for 75 months.11 The Sydney group
reported on 266 patients followed up for a minimum of 6
months (median, 24 months), of whom 43 patients re-
quired either open repair or supplementary interventions.8
Our group previously reported a 16% rate of secondary
interventions during follow-up.2,12 The EUROSTAR data
base demonstrated freedom from secondary intervention to
be 42% at 72 months, as calculated with life table analysis.7
The extent, duration, and quality of follow-up, as well
as the decision for repeat intervention, are factors that may
influence the rate of repeat intervention, and also freedom
from rupture and occlusion. The need for aneurysm and
stent graft imaging at 1, 6, and 12 months, and yearly
thereafter is underlined in all reports. However, apart from
monitored research protocols, routine practice may not be
so ideal. The rate of rupture investigated by the EURO-
STAR data base has been estimated at as high as 1% per
year. Rupture was more frequent in cases of graft migra-
tion, type I endoleak, and mid-graft endoleak. It may be
speculated that early repeat interventions in these cases may
have prevented rupture.13
Our group has organized a systematic and periodic
review of all patients treated in our institution with endo-
vascular grafts. This promoted detection of clinically silent
problems and enabled us to initiate treatment before com-
plications occurred. This aggressive policy may have pre-
vented catastrophic events, inasmuch as of yet no rupture
has occurred. The cost was a relatively high number of
repeat interventions (27%) for the entire series.
There are many reasons for repeat intervention, includ-
ing technical flaws at operation, material deterioration, and
evolution of disease in the arterial tree. Design of early
grafts, including some of those used in the current series,
was not optimum. The range of sizes was limited, and may
have accounted for a number of type I proximal and distal
endoleaks. With the Stentor, Vanguard, and EVT grafts,
only patients with aortic neck diameter less than 26 mm and
common iliac arteries initially 12 mm, then 14 mm, in
diameter could be treated. With the more recent grafts,
available sizes are increased to 36 mm at the aortic level and
up to 28 mm at the iliac level. Limb disconnections ob-
served with the Stentor and Vanguard grafts were due to
inadequate overlap between the contralateral limb and the
aortoiliac segment. The rigidity of these systems may have
also had a role. Conversely, limb and graft occlusion ob-
served with the EVT system was due to overflexibility of the
graft14 and to difficulty in deploying the graft properly.
Material fatigue is a concern with endovascular grafts.15,16
To date, two Vanguard grafts in our patients have had
fabric rupture, and conversion to open surgery was neces-
sary. These flaws have been addressed with the newer
generation grafts. Thicker fabric and designs that minimize
metal-fabric friction give hope for better durability. Fur-
thermore, current results with the newer generation grafts
are encouraging.17 Our study confirms this trend. If EVT
grafts are excluded, currently available grafts were associ-
ated with fewer secondary procedures and conversions.
However, longer follow-up with the more recent grafts is
necessary before firm conclusions can be drawn.
Repeat interventions were performed for a variety of
reasons and with different means. In our series, type I, type
III, and type IV endoleaks were treated with endovascular
procedures, most commonly by adding a new piece of
endograft at the presumed site of the leak. We found that
the most difficult cases to deal with were type I proximal
endoleaks. The main risks of putting a new graft in the
infrarenal neck are blocking the renal arteries if it is placed
Table V. Data in patients who underwent conversion to open surgery after EVAR
Patient Endograft
Time to
conversion
(mo)
AAA
Initial
diameter
(mm)
AAA
diameter at
conversion
(mm) Endoleak
Occlusion/
stenosis Outcome
1 EVT 3 47 47 — yes Alive
2 Talent 4 52 60 Type I, proximal no Alive
3 Vanguard 14 72 75 Type I, proximal no Alive
4 Stentor 29 58 67 Type I, distal no Dead, 7 mo
postoperatively
5 Vanguard 38 46 69 Type III no Alive
6 EVT 36 55 65 Type I, distal Alive
7 Vanguard 71 60 60 Type III Alive (stroke)
8 Stenway 78 52 52 — yes Alive
9* AneuRx 38 80 95 Type I, proximal no Alive
10* AneuRx 3 58 68 Type I, proximal no Alive
11* Vanguard 26 72 80 Type III no Alive
EVAR, Endovascular repair of aortic aneurysm; AAA, abdominal aortic aneurysm.
*Secondary procedure not attempted, because of large and rapidly expanding aneurysm and uncertainty concerning ability of a secondary procedure to fix the
leak.
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too high, and failing to treat the leak if it is placed too low.
In addition, mobilization or destabilization of the former
graft by the introducer system of the new graft is of con-
cern. Conversely, distal type I endoleaks resulting from
common iliac artery enlarging, as well as graft limb discon-
nections, were generally successfully treated with a percu-
taneous approach from the groin or a combined groin-
brachial artery approach.
Endovascular conversion is, in our view, an excellent
tool to precisely deliver a new piece of graft. Proximal cuffs
are difficult to place properly, owing to their short length,
lack of proximal bare stents, and the absence of hooks. Also,
in the long run the proximal cuff may fall apart.18 With a
new aortoiliac graft, handling is much easier and the deliv-
ery is more precise. We have chosen the Cook device for this
procedure, because we have found deployment to be quite
accurate and because we suspect that the presence of hooks
may improve long-term fixation. Endovascular conversion
is also a useful strategy when one limb cannot be catheter-
ized because of severe kinking or disconnection. This tech-
nique had been used with success in similar situations by
Teruya et al19 and Teufelsbauer et al.20
Early treatment of type II endoleak is controversial,
inasmuch as 60% occlude spontaneously.21,22 We were
relatively aggressive in treating type II endoleaks, especially
in patients with very large aneurysms or aneurysms that
enlarged during follow-up. Although some may question
whether all of our coil embolizations were necessary, we
believed that growing aneurysms should not be left un-
treated. That led us to attempt a substantial number of
lumbar or mesenteric coil embolizations, which may over-
estimate the rate of secondary procedures. Similar to what
has been reported by others,23,24 we were relatively suc-
cessful in our attempts to block backbleeding from the
inferior mesenteric artery through a superior mesenteric
approach. However, blocking of lumbar arteries was tech-
nically much more challenging, and our early results were
disappointing. This confirms the 60% failure rate for type II
coil embolization reported by Solis et al.25 Failures in their
series, as in our own, were due to persistent flow though the
coils, retiform anastomosis around the coiled vessels, and
new type II endoleak. With increased experience, however,
we found that coil embolization of all patent lumbar arter-
ies by selective catheterization of both hypogastric arteries
was more efficient. In our most recent cases we have used a
combination of coils and glue, which seems to work well. In
two cases we used direct puncture of the sac, as proposed by
Baum et al10; both failed. After failed embolization, lapa-
roscopic treatment appears to be a promising approach.
While the graft is left in place, the leak can be treated and
the aneurysm reduced. This technique was successful in one
of our patients. A slightly different approach was reported
by Kolvenbach et al,26 who clipped the lumbar arteries
from outside the sac and then secured the graft with a
suture to the aortic wall.
Most stenoses and occlusions occurred with the Van-
guard and EVT grafts. Kinking or twisting of the limb was
the principal cause.14 When the limbs were still patent and
not too angulated, angioplasty with stenting was successful
in most cases. When totally occluded, thrombolysis was
attempted, with relatively disappointing results. We cur-
rently favor crossover femorofemoral bypass when one limb
remains patent. Of note, however, is that in two femoro-
femoral grafts infections developed at the groin. Previous
punctures or incisions were probably the main reason.
Surgical conversion was necessary in 4.4% of our cases.
This figure is in the range reported by the Sydney group
(6.3%, 17 of 266),8 although most of their conversions
were required within the first postoperative month. Our
number is higher than those reported from the EURO-
STAR data base (1.4%, 41 of 2862)13 and the Montefiore
series (2.1%, 5 of 239%).11
In 8 of 11 patients, conversion was performed after
failed endovascular salvage attempts (one to five). In the
remaining 3 patients conversion was performed primarily
because of a large and rapidly expanding aneurysm, and
uncertainty concerning the ability of a secondary procedure
to fix the leak.
In this group of patients, we chose a transperitoneal
route with infrarenal clamping for grafts without hooks,
and a retroperitoneal route with suprarenal clamping for
failed EVT grafts. With this strategy, surgery was relatively
straightforward, the grafts slipped out relatively easily, and
outcomes were uneventful.
The most positive finding regarding repeat interven-
tions was the low rate of life-threatening complications.
Eighty-seven percent of our repeat interventions were en-
dovascular, requiring only local anesthesia and a short
hospitalization. Survival curves showed no differences be-
tween patients who required a secondary operation and
those who did not. Also, ultimately results were good in the
11 patients with surgical conversion and 9 with femoro-
femoral grafts. This experience is shared by May et al.8
Conversely, the Montefiore11 and EUROSTAR series were
less optimistic. In the EUROSTAR series the death rate for
conversion, excluding rupture, was 24% (10 of 41).13
In the group of patients with repeat interventions,
clinical success according to the definition of Reporting
Standards for Endovascular Repair was 45 of 68 (66%). It
was significantly greater in the group of patients who did
not require repeat intervention (94%). For the entire series
the clinical success rate was 84%, which falls within the
range reported by May et al.8,17 Zarins et al27 reported the
4-year Medtronic experience, and showed that in patients
treated with endovascular grafts open surgery was avoided
after 3 years in 93%.
In conclusion, with close follow-up and a significant
number of secondary operations, this 8-year experience has
not included any aneurysm ruptures to date. Secondary
operations did not lead to increased mortality, but were
associated with increased need for conversion to open
surgery and with a higher clinical failure rate. The role of
endovascular conversion, laparoscopic adjunct, and newer
techniques of coil embolization that may reduce the num-
ber of surgical conversions after endovascular repair of AAA
should be further explored to assess their efficacy. Finally, it
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may be speculated that with newer grafts overall success will
increase and the need for secondary procedures will de-
crease.
We thank Prof Marc Coggia for assistance with success-
ful laparoscopic treatment of type II endoleaks.
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DISCUSSION
Dr Thomas S. Riles (New York, NY). Do you feel that the
glue that you’re using for repair is going to be the mainstay of your
repairs of these types of leaks in the future?
Dr Jean-Pierre Becquemin. We were disappointed by the use
of coil embolization alone. It worked with a single lumbar artery.
But with multiple arteries the coils were not sufficient, even with
large coils. So it seemed that with glue and coils the rate of closure
was improved.
Dr Alexandre C. d’Audiffret (Minneapolis, Minn). Jean-
Pierre, did you do the breakdown according to the type of endo-
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prosthesis used? And were the reintervention and complication
rates comparable?
Dr Becquemin. We started our endovascular program in
1995 with the late Vanguard stent grafts, and we currently know
that these grafts were not perfect. As a matter of fact, many
reinterventions were performed in patients with these early
generation grafts. We did some statistics that tend to prove that
the most recent grafts work much better. However, the fol-
low-up with recent grafts is not long enough to draw firm
conclusions.
Dr John H. N. Wolfe (London, England). Very interesting
study. Jean-Pierre, I was a little worried about the proximal neck
endovascular repairs. That looked very hairy to me, very close to
the renal arteries. And I wonder whether, with your information
now, you might consider going directly to open repair of that
particular problem?
Dr Becquemin. Well, it probably depends on the length of
the neck. If you have migration with a relatively long neck, I think
it is better to go for ndovascular conversion. Under these circum-
stances the aortouniiliac Cook device is relatively easy to place
within a failing graft. I think it is much more reliable than just to
place a proximal cuff, which is short and difficult to handle.
If the proximal neck is short, it may be safer to go directly for
open surgery. I agree with that.
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